1-Deoxynojirimycin Alleviates Insulin Resistance via Activation of Insulin Signaling PI3K/AKT Pathway in Skeletal Muscle of db/db Mice

1-Deoxynojirimycin (DNJ) is widely used for the treatment of diabetes mellitus as an inhibitor of intestinal α-glucosidase. However, there are few reports about its effect on insulin sensitivity improvement. The aim of the present study was to investigate whether DNJ decreased hyperglycemia by impro...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Qingpu, Li, Xuan, Li, Cunyu, Zheng, Yunfeng, Peng, Guoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331926/
https://www.ncbi.nlm.nih.gov/pubmed/26690098
http://dx.doi.org/10.3390/molecules201219794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331926/
https://www.ncbi.nlm.nih.gov/pubmed/26690098
http://dx.doi.org/10.3390/molecules201219794

Ejemplares similares